Partnering Teams to Optimize the Care of Patients With HER2-Positive Breast Cancer

por Mayer, Erica L.
Publicado 2020

Clinical trial update: implications and management of residual disease after neoadjuvant therapy for breast cancer

por Mayer, Erica L, Carey, Lisa A, Burstein, Harold J
Publicado 2007

The dilemma of selecting a first line CDK4/6 inhibitor for hormone receptor-positive/HER2-negative metastatic breast cancer

por Grinshpun, Albert, Tolaney, Sara M., Burstein, Harold J., Jeselsohn, Rinath, Mayer, Erica L.
Publicado 2023

Safety of adjuvant CDK4/6 inhibitors during the COVID-19 pandemic

por Pfeiler, Georg, DeMichele, Angela, Dueck, Amylou C, Fesl, Christian, Gnant, Michael, Mayer, Erica L
Publicado 2022

Contemporary multidisciplinary treatment of pregnancy-associated breast cancer

por Meisel, Jane L, Economy, Katherine E, Calvillo, Katherina Zabicki, Schapira, Lydia, Tung, Nadine M, Gelber, Shari, Kereakoglow, Sandra, Partridge, Ann H, Mayer, Erica L
Publicado 2013

Prospective clinical experience with research biopsies in breast cancer patients

por Vaz-Luis, Ines, Zeghibe, Catherine A., Frank, Elizabeth S., Sohl, Jessica, Washington, Kimberly E., Silverman, Stuart G., Fonte, Joseph M., Mayer, Erica L., Overmoyer, Beth A., Richardson, Andrea L., Krop, Ian E., Winer, Eric P., Lin, Nancy U.
Publicado 2013

Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging: Radiology Scientific Expert Panel

por Becker, Anton S., Perez-Johnston, Rocio, Chikarmane, Sona A., Chen, Melissa M., El Homsi, Maria, Feigin, Kimberly N., Gallagher, Katherine M., Hanna, Ehab Y., Hicks, Marshall, Ilica, Ahmet T., Mayer, Erica L., Shinagare, Atul B., Yeh, Randy, Mayerhoefer, Marius E., Hricak, Hedvig, Vargas, H. Alberto
Publicado 2021

RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer

por Koh, Siang-Boon, Ross, Kenneth, Isakoff, Steven J., Melkonjan, Nsan, He, Lei, Matissek, Karina J., Schultz, Andrew, Mayer, Erica L., Traina, Tiffany A., Carey, Lisa A., Rugo, Hope S., Liu, Minetta C., Stearns, Vered, Langenbucher, Adam, Saladi, Srinivas Vinod, Ramaswamy, Sridhar, Lawrence, Michael S., Ellisen, Leif W.
Publicado 2021

Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers

por Batalini, Felipe, Gulhan, Doga C., Mao, Victor, Tran, Antuan, Polak, Madeline, Xiong, Niya, Tayob, Nabihah, Tung, Nadine M., Winer, Eric P., Mayer, Erica L., Knappskog, Stian, Lønning, Per E., Matulonis, Ursula A., Konstantinopoulos, Panagiotis A., Solit, David B., Won, Helen, Eikesdal, Hans P., Park, Peter J., Wulf, Gerburg M.
Publicado 2022

Single duplex DNA sequencing with CODEC detects mutations with high sensitivity

por Bae, Jin H., Liu, Ruolin, Roberts, Eugenia, Nguyen, Erica, Tabrizi, Shervin, Rhoades, Justin, Blewett, Timothy, Xiong, Kan, Gydush, Gregory, Shea, Douglas, An, Zhenyi, Patel, Sahil, Cheng, Ju, Sridhar, Sainetra, Liu, Mei Hong, Lassen, Emilie, Skytte, Anne-Bine, Grońska-Pęski, Marta, Shoag, Jonathan E., Evrony, Gilad D., Parsons, Heather A., Mayer, Erica L., Makrigiorgos, G. Mike, Golub, Todd R., Adalsteinsson, Viktor A.
Publicado 2023

Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer: The Phase 2 TBCRC041 Randomized Clinical Trial

por Haddad, Tufia C., Suman, Vera J., D’Assoro, Antonino B., Carter, Jodi M., Giridhar, Karthik V., McMenomy, Brendan P., Santo, Katelyn, Mayer, Erica L., Karuturi, Meghan S., Morikawa, Aki, Marcom, P. Kelly, Isaacs, Claudine J., Oh, Sun Young, Clark, Amy S., Mayer, Ingrid A., Keyomarsi, Khandan, Hobday, Timothy J., Peethambaram, Prema P., O’Sullivan, Ciara C., Leon-Ferre, Roberto A., Liu, Minetta C., Ingle, James N., Goetz, Matthew P.
Publicado 2023

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

por Parsons, Heather A., Blewett, Timothy, Chu, Xiangying, Sridhar, Sainetra, Santos, Katheryn, Xiong, Kan, Abramson, Vandana G., Patel, Ashka, Cheng, Ju, Brufsky, Adam, Rhoades, Justin, Force, Jeremy, Liu, Ruolin, Traina, Tiffany A., Carey, Lisa A., Rimawi, Mothaffar F., Miller, Kathy D., Stearns, Vered, Specht, Jennifer, Falkson, Carla, Burstein, Harold J., Wolff, Antonio C., Winer, Eric P., Tayob, Nabihah, Krop, Ian E., Makrigiorgos, G. Mike, Golub, Todd R., Mayer, Erica L., Adalsteinsson, Viktor A.
Publicado 2023

Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes

por Lenz, Lauren, Neff, Chris, Solimeno, Cara, Cogan, Elizabeth S., Abramson, Vandana G., Boughey, Judy C., Falkson, Carla, Goetz, Matthew P., Ford, James M., Gradishar, William J., Jankowitz, Rachel C., Kaklamani, Virginia G., Marcom, P. Kelly, Richardson, Andrea L., Storniolo, Anna Maria, Tung, Nadine M., Vinayak, Shaveta, Hodgson, Darren R., Lai, Zhongwu, Dearden, Simon, Hennessy, Bryan T., Mayer, Erica L., Mills, Gordon B., Slavin, Thomas P., Gutin, Alexander, Connolly, Roisin M., Telli, Melinda L., Stearns, Vered, Lanchbury, Jerry S., Timms, Kirsten M.
Publicado 2023